4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000215
Pres. Diagnostics & Genom gave up 869 shares (to pay taxes)
- Pres. Diagnostics & Genom acquired 1,691 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kelderman Kim · Pres. Diagnostics & Genom
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-08 | Exercise or conversion : show line 1 in the form | +1,691 | 1,691 | D | ||
| 2021-08-08 | Shares withheld for taxes : show line 2 in the form | −869 | $481.82 | $418,702 | 822 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-08 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,691 | 0 | D |
| 2021-08-06 | Grant or award : show line 4 in the form Restricted Stock Units | +1,245 | 1,245 | D |
| 2021-08-06 | Grant or award : show line 5 in the form Stock Options (Right to Buy) | +4,864 | 4,864 | D |
| 2021-08-06 | Grant or award : show line 6 in the form Stock Options (Right to Buy) | +6,486 | 6,486 | D |
Loading xslF345X03/edgar.xml…